What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Emma E. Furth mostly deals with Cancer research, Pathology, Internal medicine, Immunology and Carcinoma.
The various areas that Emma E. Furth examines in her Cancer research study include Cadherin, Pancreatic cancer and Adenocarcinoma.
Her work on Immunohistochemistry, Fibrosis and Metaplasia as part of her general Pathology study is frequently connected to Banff schema, thereby bridging the divide between different branches of science.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology, Steroidogenic acute regulatory protein and Akt/PKB signaling pathway.
Her work investigates the relationship between Gastroenterology and topics such as Biopsy that intersect with problems in Barrett's esophagus and Lymph node.
Her Carcinoma study combines topics in areas such as Cancer, Surgery, Chemotherapy, Hepatocellular carcinoma and Monoclonal antibody.
Her most cited work include:
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy (1506 citations)
- Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice (1288 citations)
- Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster (937 citations)
What are the main themes of her work throughout her whole career to date?
Emma E. Furth focuses on Internal medicine, Pathology, Gastroenterology, Cancer research and Radiology.
Her research integrates issues of Endocrinology, Surgery and Oncology in her study of Internal medicine.
Her Pathology research incorporates themes from Transplantation and Pancreas.
Emma E. Furth interconnects Esophagus and Retrospective cohort study in the investigation of issues within Gastroenterology.
Her Esophagus study deals with Barrett's esophagus intersecting with Dysplasia.
Emma E. Furth usually deals with Cancer research and limits it to topics linked to Immunology and Ulcerative colitis.
She most often published in these fields:
- Internal medicine (38.05%)
- Pathology (33.67%)
- Gastroenterology (24.58%)
What were the highlights of her more recent work (between 2012-2021)?
- Internal medicine (38.05%)
- Hepatocellular carcinoma (9.09%)
- Gastroenterology (24.58%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Internal medicine, Hepatocellular carcinoma, Gastroenterology, Pathology and Cancer research.
Her work is dedicated to discovering how Internal medicine, Oncology are connected with Colorectal cancer, Exceptional Responder and KRAS and other disciplines.
In her study, Stage and General surgery is strongly linked to Radiology, which falls under the umbrella field of Hepatocellular carcinoma.
Her study focuses on the intersection of Gastroenterology and fields such as Carcinoma with connections in the field of Immunology.
The study of Pathology is intertwined with the study of Tumor marker in a number of ways.
She combines subjects such as Carcinogenesis, Cancer, Pancreatic cancer, Phenotype and Transcription factor with her study of Cancer research.
Between 2012 and 2021, her most popular works were:
- Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma (647 citations)
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma. (235 citations)
- EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration (196 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Emma E. Furth focuses on Cancer research, Internal medicine, Carcinoma, Pancreatic cancer and Pathology.
Her research in Cancer research is mostly focused on Hepatocellular carcinoma.
The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine.
The concepts of her Carcinoma study are interwoven with issues in Tumor microenvironment, Cancer, Chemotherapy and Immunology, Lymph node.
Her Pancreatic cancer research includes elements of Epithelial–mesenchymal transition, Pancreatic Intraepithelial Neoplasia, CDKN2A, GNAS complex locus and ARID1A.
The Pathology study combines topics in areas such as Acute cellular rejection, Allograft rejection and Antibody mediated rejection.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
